Paroxetine treatment of pathological gambling: A multi-centre randomized controlled trial

International Clinical Psychopharmacology

Volumn 18, Issue 4, 2003, Pages 243-249

  Grant, Jon E ^a   Kim, Suck Won ^a   Potenza, Marc N ^b   Blanco, Carlos ^c   Ibanez, Angela ^d   Stevens, Lee ^e   Hektner, Joel M ^f   Zaninelli, Rocco ^g  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF ALCALÁ   (Spain)

^e LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f NORTH DAKOTA STATE UNIVERSITY   (United States)

^g NONE   (United States)

Author keywords

Clinical trial; Impulse control; Paroxetine; Pathological gambling; Placebo response; Selective serotonin reuptake inhibitors

Indexed keywords

FLUVOXAMINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; IMPULSE CONTROL DISORDER; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OUTCOMES RESEARCH; OUTPATIENT; PATHOLOGICAL GAMBLING; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SAMPLING; SEROTONINERGIC SYSTEM; XEROSTOMIA;

EID: 0038441890     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200307000-00007     Document Type: Article

References (34)

1. American Psychiatric Association (1993). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
2. Black DW, Moyer T (1998). Clinical features and psychiatric comorbidity of subjects with pathological gambling behavior. Psychiatr Serv 49:1434-1439.
3. Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J (2002). A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 14:9-15.
4. Blaszczynski A, Silove D (1996), Pathological gambling: forensic issues. Aust NZ J Psychiatry 30:358-369.
5. Coccaro EF (1996). Neurotransmitter correlates of impulsive aggression in humans. Ann NY Acad Sci 794:82-89.
6. DeCaria CM, Begaz T, Hollander E (1998). Serotonergic and noradrenergic function in pathological gambling. CNS Spectr 3:38-47.
7. DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS (1991). The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol 59:295-304.
8. Doudet D, Hommer D, Higley JD, Andreason PJ, Moneman R, Suomi SJ et al. (1995). Cerebral glucose metabolism, CSF 5-HIAA levels, and aggressive behavior in rhesus monkeys. Am J Psychiatry 152:1782-1787.
9. First MB, Spitzer RL, Gibbon M, Williams JBW (1995). Structured Clinical Interview for DSM-IV Patient edn, SCID-I/P, Version 2.0. New York: Biometrics Research Department, New York State Psychiatric Institute.
10. Grant JE, Kim SW (2001). Demographic and clinical features of 131 adult pathological gamblers. J Clin Psychiatry 62:957-962.
11. Gunasekara NS, Noble S, Benfield P (1998). Paroxetine: an update of its pharmacology and therapeutic use in depression and a review of its use in other disorders. Drugs 55:85-120.
12. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health, pp. 218-222.
13. Hamilton M (1959). The assessment of anxiety states by rating. Br J Med Psychiatry 32:50-55.
14. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
15. Hollander E, DeCaria CM, Mari E, Wong CM, Mosovich S, Grossman R, et al. (1998). Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry 155:1781-1783.
16. Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C (2000). A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biol Psychiatry 47:813-817.
17. Ibanez A, Blanco C, Donahue E, Lesieur, de Castro IP, Fernandez-Piqueras J, et al. (2001). Psychiatric comorbidity in pathological gamblers seeking treatment. Am J Psychiatry 158:1733-1735.
18. Kim SW, Grant JE, Adson DE, Shin YC (2001). Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 49:914-921.
19. Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R (2002). A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 63:501-507.
20. Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA, for the Veterans Affairs Naltrexone Cooperative Study 425 Group (2001). Naltrexone in the treatment of alcohol dependence. N Eng J Med 345:1734-1739.
21. Lesieur HR, Blume SB (1987). The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 144:1184-1188.
22. McCormick RA, Russo AM, Rameriz LF, Taber JI (1984). Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry 141:215-218.
23. Mehlman PT, Higley JD, Faucher I (1995). Low CSF 5-HIAA concentrations and severe aggression and impaired impulse control in nonhuman primates. Am J Psychiatry 151:1485-1491.
24. Moreno I, Saiz-Ruiz J, Lopez-Ibor JJ (1991). Serotonin and gambling dependence. Hum Psychopharmacol 6:9-12.
25. O'Malley SS, Jaffe A, Change G (1992). Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49: 881-887.
26. Petry NM, Roll JM (2001). A behavioral approach to understanding and treating pathological gambling. Semin Clin Neuropsychiatry 6:177-183.
27. Roy A, Ardinoff B, Roehrich L, Lamparski D, Custer R, Lorenz V, et al. (1988). Pathological gambling: a psychobiological study. Arch Gen Psychiatry 45:369-373.
28. Shaffer HJ, Hall MN (1996). Estimating the prevalence of adolescent gambling disorders: a quantitative synthesis and guide toward standard gambling nomenclature. J Gambling Studies 12:193-214.
29. Shaffer HJ, Hall MN, Vander Bilt J (1999). Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Pub Health 89:1369-1376.
30. Sheehan DV (1983) The Anxiety Disease, New York: Scribner's.
31. Smart RG, Ferris J (1994). Alcohol, drugs and gambling in the Ontario adult population. Can J Psychiatry 41:36-45.
32. Virkkunen M, Goldman D, Nielsen DA (1995). Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. J Psychiatry Neurosci 20:271-275.
33. Walsh BT, Seidman SN, Sysko R, Gould M (2002). Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287:1840-1847.
34. Zimmerman M, Breen R, Posternak MA (2002). An open-label study of citalopram in the treatment of pathological gambling. J Clin Psychiatry 63:44-48.